Interestingly, amylin appears to have a synergistic effect with leptin: pre-treatment with amylin reduces the leptin resistance observed in obesity and leads to a mean weight loss of 12.7% when given in combination with recombinant leptin in a proof of concept trial (49, 50). Here, IAPP is linked to obesity due to melanocortin 4 receptor deficiency.